Portage Biotech Inc. (NASDAQ: PRTG)
$0.18
+0.0013 ( +0.72% ) 580.1K
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
Market Data
Open
$0.18
Previous close
$0.18
Volume
580.1K
Market cap
$3.76M
Day range
$0.17 - $0.20
52 week range
$0.13 - $3.60
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 1 | May 01, 2024 |
6-k | Quarterly Reports | 2 | Apr 12, 2024 |
6-k | Quarterly Reports | 1 | Mar 08, 2024 |
6-k | Quarterly Reports | 19 | Mar 07, 2024 |
6-k | Quarterly Reports | 2 | Feb 29, 2024 |
6-k | Quarterly Reports | 105 | Feb 28, 2024 |
6-k | Quarterly Reports | 19 | Jan 18, 2024 |
6-k | Quarterly Reports | 2 | Jan 04, 2024 |
6-k | Quarterly Reports | 92 | Nov 28, 2023 |
6-k | Quarterly Reports | 2 | Nov 28, 2023 |